Skip to main content
OpenTrials

Clinical trial condition

Hyperparathyroidism, Secondary

Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.

146 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Hyperparathyroidism, Secondary trial results

Completed

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

NCT01290029

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site Kansas City, Missouri, United States
View Trial Details
Completed

Phase 3 Study of SK-1403

NCT03801980

Conditions
Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations
  • Investigational site (there may be other sites in this country) Tokyo, Japan
View Trial Details
Completed

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

NCT03283098

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Nanjing, Jiangsu, China
  • Research Site Shanghai, Shanghai Municipality, China
  • Research Site Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

NCT02274623

Conditions
Bone Diseases, Bone Neoplasms, Breast Cancer, +25 more
Locations
  • Coast Hematology-Oncology Associates Long Beach, California, United States
  • Mount Sinai Medical Center, Comprehensive Cancer Center Miami, Florida, United States
  • Research by Design LLC Evergreen Park, Illinois, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

NCT01785849

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Azusa, California, United States
  • Research Site Covina, California, United States
View all 118 locations
View Trial Details
Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

NCT01788046

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Azusa, California, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Chula Vista, California, United States
View all 106 locations
View Trial Details

Related conditions